CoChat

Exome sequencing for patients with developmental and epileptic encephalopathies in clinical practice

Open access
Scheffer, Ingrid E., Bennett, Caitlin A., Gill, Deepak, de Silva, Michelle G., Boggs, Kirsten, Marum, Justine, Baker, Naomi, Australian Genomics DEE Flagship, Palmer, Elizabeth E., Howell, Katherine B. · 2023 · Developmental Medicine & Child Neurology
Cited by 31

The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.

Abstract

Aim: To assess the clinical utility of exome sequencing for patients with developmental and epileptic encephalopathies (DEEs). Method: Over 2 years, patients with DEEs were recruited for singleton exome sequencing. Parental segregation was performed where indicated. Results: Of the 103 patients recruited (54 males, 49 females; aged 2 weeks–17 years), the genetic aetiology was identified in 36 out of 103 (35%) with management implications in 13 out of 36. Exome sequencing revealed pathogenic or likely pathogenic variants in 30 out of 103 (29%) patients, variants of unknown significance in 39 out of 103 (38%), and 34 out of 103 (33%) were negative on exome analysis. After the description of new genetic diseases, a molecular diagnosis was subsequently made for six patients or through newly available high‐density chromosomal microarray testing. Interpretation: We demonstrate the utility of exome sequencing in routine clinical care of children with DEEs. We highlight that molecular diagnosis often leads to changes in management and informs accurate prognostic and reproductive counselling. Our findings reinforce the need for ongoing analysis of genomic data to identify the aetiology in patients in whom the cause is unknown. The implementation of genomic testing in the care of children with DEEs should become routine in clinical practice. What this paper adds: The cause was identified in 35% of patients with developmental and epileptic encephalopathies. KCNQ2, CDKL5, SCN1A, and STXBP1 were the most frequently identified genes. Reanalysis of genomic data found the cause in an additional six patients. Genetic aetiology was identified in 41% of children with seizure onset under 2 years, compared to 18% with older onset. Finding the molecular cause led to management changes in 36% of patients with DEEs.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/dmcn.15308

Cites

16 of 16 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 16 references

Cited by

See all 31

Metadata

Authors
Scheffer, I. E., Bennett, C. A., Gill, D., de Silva, M. G., Boggs, K., Marum, J., Baker, N., Flagship, A. G. D., Palmer, E. E., & Howell, K. B.
Venue
Developmental Medicine & Child Neurology
Publisher
Wiley
Published
2022-06-14
Volume
65
Issue
1
Pages
50-57
ISSN
  • 0012-1622 (ISSN-L)
  • 1469-8749
OpenAlex
W4282922745
Cited by
31
References
16
FWCI
3.93
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Exome sequencing for patients with developmental and epileptic encephalopathies in clinical practice. https://app.cochat.ai/papers/10.1111/dmcn.15308
The paper
Scheffer, I. E., Bennett, C. A., Gill, D., de Silva, M. G., Boggs, K., Marum, J., Baker, N., Flagship, A. G. D., Palmer, E. E., & Howell, K. B. (2023). Exome sequencing for patients with developmental and epileptic encephalopathies in clinical practice. Developmental Medicine & Child Neurology. https://doi.org/10.1111/dmcn.15308

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.